Medical cost associated with prediabetes

Population Health Management

Volumn 12, Issue 3, 2009, Pages 157-163

  Zhang, Yiduo ^a   Dall, Timothy M ^a   Chen, Yaozhu ^a   Baldwin, Alan ^b   Yang, Wenya ^a   Mann, Sarah ^a   Moore, Victoria ^b   Le Nestour, Elisabeth ^c   Quick, William W ^b  

^a LEWIN GROUP   (United States)

^b Ingenix/i3research ^*  (France)

^c Ingenix/i3research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEUROLOGIC DISEASE; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT CARE; PERIPHERAL VASCULAR DISEASE; POISSON DISTRIBUTION; PREVALENCE; PRIVATE HEALTH INSURANCE; REGRESSION ANALYSIS; SCREENING TEST;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; HEALTH EXPENDITURES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PREDIABETIC STATE; YOUNG ADULT;

EID: 67650797204     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2009.12302     Document Type: Article

References (29)

1. US Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2007. Available at: http://diabetes.niddk.nih.gov/ dm/pubs/staTIStics/DM-Statistics.pdf.
2. National Diabetes Surveillance System. Crude and age-adjusted incidence of diagnosed diabetes per 1000 population aged 18-79 years, United States, 1980-2005. Available at: http://www.cdc.gov/Diabetes/statistics/incidence/ detailtable4.htm.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
4. Santaguida PL, Balion C, Hunt D, et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Summary, Evidence Report/Technology Assessment No. 128. AHRQ Pub.No.05-E026-1. Available at: http://www.ahrq.gov/clinic/epcsums/impglusum.htm.
5. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344:1343-1350.
6. de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA. 2001;285: 2109-2113.
7. Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-332.
8. Nichols GA, Brown JB. Higher medical care costs accompany impaired fasting glucose. Diabetes Care. 2005;28:2223- 2229.
9. Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care. 2008;46:287-292.
10. DECODE Study Group, the European Diabetes Epdemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161:397-405.
11. Bjornholt JV, Erikssen G, Aaser E, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care. 1999;22:45-49.
12. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233-240.
13. Cubbon R, Kahn M, Kearney MT. Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective. Int J Clin Pract. 2008;62:287-299.
14. Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51:264-270.
15. Wong TY, Mohamed Q, Klein R, Couper DJ. Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes? Br J Ophthalmol. 2006;90:301-303.
16. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care. 2007;30: 2708-2715.
17. Bjornholt JV, Erikssen G, Kjeldsen SE, Bodegard J, Thaulow E, Erikssen J. Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure. J Hypertens. 2003;21: 1383-1389.
18. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care. 2001;24:447-453.
19. Dall T, Mann SE, Zhang Y, Martin J, Chen Y, Hogan P. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31:1-20.
20. Dall TM, Mann S, Zhang Y, et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Pop Health Manage. 2009;12:103-110.
21. National Center for Health Statistics. Survey and data collection systems. Available at: http://www.cdc.gov/nchs/Default.htm. Accessed July 2008.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(suppl 1):S55-S60.
23. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10:195-216.
24. Zhang Y, Dall TM, Mann SE, et al. The economic cost of undiagnosed diabetes. Pop Health Manage. 2009;12:95-101.
25. Boles M, Pelletier B, Lynch W. The relationship between health risks and work productivity. J Occup Environ Med. 2004;46:737-745.
26. Burton WN, Chen CY, Conti DJ, Schultz AB, Pransky G, Edington DW. The association of health risks with on-the-job productivity. J Occup Environ Med. 2005;47:769-777.
27. Burton WN, Chen CY, Conti DJ, Schultz AB, Edington DW. The association between health risk change and presenteeism change. J Occup Environ Med. 2006;48:252-263.
28. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
29. Dall T, Zhang Y, Chen YJ, et al. Cost associated with overweight and obesity, high alcohol consumption, and tobacco use within the military health system's TRICARE Prime enrolled population. Am J Health Promotion. 2007;22:120-143.